---
$id: https://graph.org.ai/products/commodity/51334416
$type: Product
source: UNSPSC
code: "51334416"
title: "Roxoperone"
class: "51334400"
classTitle: "Antipsychotics, synthesized"
family: "51330000"
familyTitle: "Antipsychotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Roxoperone

**UNSPSC Code**: 51334416
**Class**: [Antipsychotics, synthesized](Antipsychotics, synthesized.mdx)
**Family**: [Antipsychotics](../Antipsychotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anxiolytic with the molecular formula C19H23FN2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5RS1CY853F, chemically known as 2,8-diazaspiro(4.5)decane-1,3-dione, 8-(4-(4-fluorophenyl)-4-oxobutyl)-2-methyl- (9ci) but generally known as roxoperone, which bears US NIH Compound Identifier 71117. European Medicines Agency schedules Roxoperone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10402MIG. The term ROXOPERONE is an International Non-Proprietary Name. ROXOPERONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule roxoperone under HS 29333999 and SITC 51574. As of Q4 2014, ROXOPERONE remains the US FDA Preferred Term for this commodity. Roxoperone bears US NLM identifiers UMLS ID C2699117 and NCI Concept Code C76446. SMILES: FC1CCC(C(=O)CCCN2CCC3(CC2)CC(=O)N(C3=O)C)CC1.

